Literature DB >> 33384725

Predictive Factor of the Possibility for Aortic Side Branches Coil Embolization during Endovascular Abdominal Aortic Aneurysm Repair.

Atsushi Aoki1, Kazuto Maruta1, Norifumi Hosaka2, Tomoaki Masuda1, Tadashi Omoto1, Yui Horikawa1.   

Abstract

Objective: Coil embolization of aortic side branches has been additionally performed to prevent type II endoleak during EVAR in our institute. In this study, we evaluated the predictive factors of the possibility for coil embolization of the inferior mesenteric artery (IMA) and lumbar artery (LA) during EVAR.
Methods: Seventy-four EVAR patients during June 2015 and April 2019 were included in the study. The coil embolization procedural time for one vessel is limited to 10 min. Aortic side branches were selected with 4 Fr Shepherd hook type catheter (Medikit, Tokyo, Japan) and were embolized with Interlock (Boston Scientific, MA, USA) via microcatheter. As predictive factors, internal diameter of aortic side branches and the aortic diameter perpendicular to the origin of LA (aortic diameter) were evaluated.
Results: Coil embolization was tried for 52 patent IMAs and all IMAs except two IMAs with ostial stenosis were successfully coil embolized (96.2%). Totally 190 LAs were patent and coil embolization was tried for 144 LAs. Among 144 LAs, 106 LAs (73.6%) were successfully coil embolized and the diameter was significantly longer (2.30±0.51 mm vs. 2.04±0.41 mm, p=0.007) and aortic dimeter was significantly shorter (30.0±8.1 mm vs. 40.5±11.6 mm, p<0.001) in successfully embolized LAs. Cut off value of successful LA coil embolization was 2.06 mm for internal diameter and 36.1 mm for aortic diameter by receiver operating characteristic curve analysis. Successful coil embolization rate for LAs with internal diameter longer than 2.0 mm and aortic diameter less than 36.2 mm was 90% (72 among 80 LAs).
Conclusion: Coil embolization during EVAR for IMA was highly successful, if there was no calcified ostial stenosis. LA embolization was feasible especially for LAs with internal diameter ≥2.0 mm and aortic diameter ≤36.1 mm. This information would be useful to select the target vessel for aortic side branches coil embolization during EVAR. (This is a translation of Jpn J Vasc Surg 2019; 28: 389-396.).
© 2020 The Editorial Committee of Annals of Vascular Diseases.

Entities:  

Keywords:  abdominal aortic aneurysm; embolization; inferior mesenteric artery; lumbar artery; stent graft

Year:  2020        PMID: 33384725      PMCID: PMC7751085          DOI: 10.3400/avd.oa.20-00115

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  30 in total

Review 1.  Preoperative Inferior Mesenteric Artery Embolization: A Valid Method to Reduce the Rate of Type II Endoleak after EVAR?

Authors:  Jesse M Manunga; Andrew Cragg; Ross Garberich; Jonathan A Urbach; Needa Skeik; Jason Alexander; Jessica Titus; Elliot Stephenson; Peter Alden; Timothy M Sullivan
Journal:  Ann Vasc Surg       Date:  2016-08-12       Impact factor: 1.466

2.  Outcomes of endovascular aneurysm repair with contemporary volume-dependent sac embolization in patients at risk for type II endoleak.

Authors:  Michele Piazza; Francesco Squizzato; Marco Zavatta; Mirko Menegolo; Joseph J Ricotta; Sandro Lepidi; Franco Grego; Michele Antonello
Journal:  J Vasc Surg       Date:  2015-10-01       Impact factor: 4.268

3.  Inferior mesenteric artery embolization before endovascular repair of an abdominal aortic aneurysm: effect on type II endoleak and aneurysm shrinkage.

Authors:  Terhi Nevala; Fausto Biancari; Hannu Manninen; Pekka Matsi; Kimmo Mäkinen; Kari Ylönen; Jukka Perälä
Journal:  J Vasc Interv Radiol       Date:  2009-12-21       Impact factor: 3.464

4.  CT features of early type II endoleaks after endovascular repair of abdominal aortic aneurysms help predict aneurysm sac enlargement.

Authors:  René Müller-Wille; Sophie Schötz; Florian Zeman; Wibke Uller; Oliver Güntner; Karin Pfister; Piotr Kasprzak; Christian Stroszczynski; Walter A Wohlgemuth
Journal:  Radiology       Date:  2014-11-07       Impact factor: 11.105

5.  Selective Inferior Mesenteric Artery Embolization during Endovascular Abdominal Aortic Aneurysm Repair to Prevent Type II Endoleak.

Authors:  Tetsuya Fukuda; Hitoshi Matsuda; Hiroshi Tanaka; Yoshihiro Sanda; Yoshiaki Morita; Yoshimasa Seike
Journal:  Kobe J Med Sci       Date:  2018-07-03

6.  Endovascular abdominal aneurysm repair and impact of systematic preoperative embolization of collateral arteries: endoleak analysis and long-term follow-up.

Authors:  Mario Alerci; Alessia Giamboni; Rolf Wyttenbach; Alessandra Pia Porretta; Francesco Antonucci; Marcel Bogen; Marco Toderi; Adriano Guerra; Fabio Sartori; Paolo Tutta; Luigi Inglese; Costanzo Limoni; Augusto Gallino; Ludwig K Von Segesser
Journal:  J Endovasc Ther       Date:  2013-10       Impact factor: 3.487

7.  Predicting aneurysm enlargement in patients with persistent type II endoleaks.

Authors:  Carlos H Timaran; Takao Ohki; Soo J Rhee; Frank J Veith; Nicholas J Gargiulo; Hisako Toriumi; Mahmood B Malas; William D Suggs; Reese A Wain; Evan C Lipsitz
Journal:  J Vasc Surg       Date:  2004-06       Impact factor: 4.268

8.  Intraoperative intrasac thrombin injection to prevent type II endoleak after endovascular abdominal aortic aneurysm repair.

Authors:  Mario Zanchetta; Francesca Faresin; Luigi Pedon; Salvatore Ronsivalle
Journal:  J Endovasc Ther       Date:  2007-04       Impact factor: 3.487

9.  Type II endoleaks: predictable, preventable, and sometimes treatable?

Authors:  Duncan J Parry; David O Kessel; Iain Robertson; Lucy Denton; Jai V Patel; David C Berridge; Ralph C Kester; David J A Scott
Journal:  J Vasc Surg       Date:  2002-07       Impact factor: 4.268

10.  Editor's Choice - Systematic Review and Meta-Analysis of the Outcome of Treatment for Type II Endoleak Following Endovascular Aneurysm Repair.

Authors:  Klaas H J Ultee; Stefan Büttner; Roy Huurman; Frederico Bastos Gonçalves; Sanne E Hoeks; Wichor M Bramer; Marc L Schermerhorn; Hence J M Verhagen
Journal:  Eur J Vasc Endovasc Surg       Date:  2018-08-10       Impact factor: 7.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.